Online first
Research paper
Published online: 2024-03-18
Serum 25-hydroxyvitamin D is associated with homocysteine in infertile patients with polycystic ovary syndrome (PCOS)
DOI: 10.5603/gpl.94879
Pubmed: 38506476
Abstract
Objectives: The aim of the study was to investigate whether there is a relationship between serum 25-hydroxyvitamin D and homocysteine in infertile-related PCOS.
Material and methods: We retrospectively reviewed 208 participants (86 PCOS and 122 non-PCOS) who met the inclusion and exclusion criteria from March 2020 to October 2021 at the Department of Obstetrics and Gynecology of the Second affiliated hospital of Xi’an Jiaotong University. Methods of Pearson correlation and linear regression were used to evaluate the associations between serum levels of 25-hydroxyvitamin D and homocysteine in infertile-related PCOS, and a smooth curve fitting were used to address potential nonlinearity.
Results: An inverse association between serum 25-hydroxyvitamin D and homocysteine was observed (r = –0.392, p < 0.001) in PCOS groups. Multiple linear regression analysis showed serum 25-hydroxyvitamin D was independently negatively associated with homocysteine levels after controlling for confounding factors (β = –0.316, p = 0.006). Age, BMI-stratified multivariate linear regression showed that serum 25-hydroxyvitamin D were independently associated with hyperhomocysteine especially in PCOS women aged 30 years or younger after adjusting age, BMI, and AMH.
Conclusions: Herein, the current findings suggest that 25-hydroxyvitamin D levels was negatively associated with serum homocysteine in women with infertility-related PCOS.
Keywords: homocysteineinfertilityPCOSvitamin D
References
- Al Wattar BH, Fisher M, Bevington L, et al. Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study. J Clin Endocrinol Metab. 2021; 106(8): 2436–2446.
- Tsiami AP, Goulis DG, Sotiriadis AI, et al. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens). 2021; 20(3): 449–461.
- Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 131(6): 1174–1176.
- Costello MF, Misso ML, Balen A, et al. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2019; 59(6): 867–873.
- Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9): 1602–1618.
- Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5): 270–284.
- Jacewicz-Święcka M, Kowalska I. Changes in Metabolic Profile in the Women with a History of PCOS-A Long-Term Follow-Up Study. J Clin Med. 2020; 9(10).
- de Melo GB, Soares JF, Costa TC, et al. Early Exposure to High-Sucrose Diet Leads to Deteriorated Ovarian Health. Front Endocrinol (Lausanne). 2021; 12: 656831.
- Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018; 110(3): 364–79.
- Wang J, You D, Wang H, et al. Association between homocysteine and obesity: A meta-analysis. J Evid Based Med. 2021; 14(3): 208–217.
- Razi Y, Eftekhar M, Fesahat F, et al. Concentrations of homocysteine in follicular fluid and embryo quality and oocyte maturity in infertile women: a prospective cohort. J Obstet Gynaecol. 2021; 41(4): 588–593.
- Wyse ATS, Bobermin LD, Dos Santos TM, et al. Homocysteine and Gliotoxicity. Neurotox Res. 2021; 39(3): 966–974.
- Kondapaneni V, Gutlapalli SD, Poudel S, et al. Significance of Homocysteine Levels in the Management of Polycystic Ovarian Syndrome: A Literature Review. Cureus. 2020; 12(10): e11110.
- Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012; 166(5): 765–778.
- Abadia L, Gaskins AJ, Chiu YH, et al. Environment and Reproductive Health Study Team. Serum 25-hydroxyvitamin D concentrations and treatment outcomes of women undergoing assisted reproduction. Am J Clin Nutr. 2016; 104(3): 729–735.
- Mu Y, Cheng D, Yin TL, et al. Vitamin D and Polycystic Ovary Syndrome: a Narrative Review. Reprod Sci. 2021; 28(8): 2110–2117.
- He C, Lin Z, Robb SW, et al. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2015; 7(6): 4555–4577.
- Amer M, Qayyum R. The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults. J Clin Endocrinol Metab. 2014; 99(2): 633–638.
- Al-Bayyari N, Al-Zeidaneen S, Hailat R, et al. Vitamin D prevents cardiovascular diseases by lowering serum total homocysteine concentrations in overweight reproductive women: A randomized, placebo-controlled clinical trial. Nutr Res. 2018; 59: 65–71.
- Glueck CJ, Jetty V, Rothschild M, et al. Associations between Serum 25-hydroxyvitamin D and Lipids, Lipoprotein Cholesterols, and Homocysteine. N Am J Med Sci. 2016; 8(7): 284–290.
- Kaya B, Ates E, Paydas S, et al. Evaluation of the Relationship Between Homocysteine, Parathormone, Vitamin D, and Bone Mineral Densitometry in Recipients of Kidney Transplant. Transplant Proc. 2019; 51(7): 2324–2329.
- Ota K, Takahashi T, Han A, et al. Effects of MTHFR C677T polymorphism on vitamin D, homocysteine and natural killer cell cytotoxicity in women with recurrent pregnancy losses. Hum Reprod. 2020; 35(6): 1276–1287.
- Irani M, Merhi Z. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertil Steril. 2014; 102(2): 460–468.e3.
- Blomberg Jensen M. Vitamin D and male reproduction. Nat Rev Endocrinol. 2014; 10(3): 175–186.
- Arslan S, Akdevelioğlu Y. The Relationship Between Female Reproductive Functions and Vitamin D. J Am Coll Nutr. 2018; 37(6): 546–551.
- Klimczak AM, Franasiak JM. Vitamin D in human reproduction: some answers and many more questions. Fertil Steril. 2021; 115(3): 590–591.
- Voulgaris N, Papanastasiou L, Piaditis G, et al. Vitamin D and aspects of female fertility. Hormones (Athens). 2017; 16(1): 5–21.
- Rudnicka E, Suchta K, Grymowicz M, et al. Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021; 22(7).
- Zhang B, Qi X, Zhao Y, et al. Elevated CD14CD16 Monocytes in Hyperhomocysteinemia-Associated Insulin Resistance in Polycystic Ovary Syndrome. Reprod Sci. 2018; 25(12): 1629–1636.
- Meng Y, Chen X, Peng Z, et al. Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(6): e0157389.
- Sahin Ersoy G, Altun Ensari T, Vatansever D, et al. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile. Gynecol Endocrinol. 2017; 33(2): 119–123.
- Pham TM, Ekwaru JP, Mastroeni SS, et al. The Effect of Serum 25-Hydroxyvitamin D on Elevated Homocysteine Concentrations in Participants of a Preventive Health Program. PLoS One. 2016; 11(8): e0161368.
- Ganji V, Tangpricha V, Zhang Xu. Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitness in US Adults. Nutrients. 2020; 12(3).
- Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol. 2011; 91(2): 115–124.
- Herrick KA, Storandt RJ, Afful J, et al. Vitamin D status in the United States, 2011-2014. Am J Clin Nutr. 2019; 110(1): 150–157.
- Xu R, Huang F, Wang Y, et al. Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep. 2020; 10(1): 17401.
